Quick Summary

Rooibos (Aspalathus linearis) is a South African plant commonly consumed as fermented (red) or unfermented (green) tea. It contains polyphenols such as aspalathin, isoorientin, and rutin. Limited human clinical studies suggest that rooibos tea consumption may improve lipid profiles, antioxidant status, and blood glucose levels in both healthy and at-risk individuals. Laboratory research indicates antioxidant and selective antibacterial activities, although anticancer effects have not been confirmed in vitro at tested doses. Safety data, drug interaction potential, and contraindications remain limited, with no serious adverse effects reported in human studies. Further rigorous clinical research is needed to better understand its therapeutic potential and safety profile.

What is it

Rooibos is a leguminous shrub native to South Africa. It is widely prepared as a herbal tea in either fermented form (red rooibos) or unfermented form (green rooibos). The plant’s leaves are rich in unique polyphenolic compounds, which contribute to its possible health-related properties and antioxidant capacity.

Traditional Uses

Traditionally, rooibos tea has been used as a caffeine-free beverage with potential calming effects. It has also been used in folk medicine for digestive issues and to promote overall wellness. Its modern use focuses largely on its antioxidant content and potential benefits for heart and metabolic health.

Active Compounds

  • Aspalathin
  • Isoorientin
  • Rutin
  • Other polyphenols and flavonoids

Potential Benefits with Evidence Levels

Potential Benefits Supported by Limited Human Clinical Evidence

  • Improvement in lipid profiles in healthy and at-risk individuals
  • Enhancement of antioxidant status
  • Reduction of blood glucose levels

In Vitro and Animal Evidence

  • Antioxidant activity measured by DPPH assay
  • Antibacterial effects against certain bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa
  • Partial hepatic antioxidant protection in oxidative stress-induced rat models

No Confirmed Effect

No confirmed anticancer activity was observed in vitro against certain cancer cell lines at tested concentrations.

Side Effects

No adverse effects have been explicitly reported in human clinical studies to date. Animal studies have not shown toxicity or body weight impairment at dietary relevant doses.

Drug Interactions

Currently, no direct evidence exists regarding drug interactions involving rooibos. Further research is required to clarify potential interactions.

Who Should Avoid It

No specific contraindications have been identified from available literature. Due to limited safety data, cautious use is advised, particularly during pregnancy and breastfeeding.

Pregnancy and Breastfeeding

Animal studies suggest that red rooibos consumption may partially support recovery of maternal bone mineral density after pregnancy and lactation. However, no human data are available, so cautious use is recommended until more safety information is established.

Evidence Limitations

  • Limited number of human clinical trials with small sample sizes
  • Variability in rooibos types (fermented vs. unfermented) and dosages across studies
  • Majority of data come from in vitro and animal studies, limiting direct application to humans
  • Lack of high-quality randomized controlled trials evaluating efficacy and safety
  • Insufficient information on long-term safety, drug interactions, and use in special populations

References

Last Reviewed

June 2024

Disclaimer: This page is for informational purposes only and does not provide medical advice. Consult a healthcare professional before starting any new herbal supplement or treatment, especially if you have existing health conditions or are taking medications.